OSCR

Oscar Health, Inc. Announces Inducement Grants under Section 303A.08 of the NYSE Listed Company Manual

Retrieved on: 
Friday, January 26, 2024

Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, announced that on January 22, 2024 the Compensation Committee of Oscar’s Board of Directors approved the grant of employment inducement restricted stock unit awards covering an aggregate of 104,586 Class A shares of Oscar’s common stock to 11 new non-executive employees of Oscar and its affiliates, to induce them to join Oscar and its affiliates.

Key Points: 
  • Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, announced that on January 22, 2024 the Compensation Committee of Oscar’s Board of Directors approved the grant of employment inducement restricted stock unit awards covering an aggregate of 104,586 Class A shares of Oscar’s common stock to 11 new non-executive employees of Oscar and its affiliates, to induce them to join Oscar and its affiliates.
  • The awards generally vest quarterly over a one-year period following their vesting commencement date, subject to continued employment.
  • The awards were granted under Oscar’s 2022 Employment Inducement Award Plan as employment inducement awards pursuant to the New York Stock Exchange rules.

Oscar Health, Inc. 2023 Fourth Quarter and Full Year Earnings Conference Call

Retrieved on: 
Thursday, January 18, 2024

Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, will release its fourth quarter and full year 2023 financial results after the market closes on Wednesday, February 7, 2024.

Key Points: 
  • Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, will release its fourth quarter and full year 2023 financial results after the market closes on Wednesday, February 7, 2024.
  • Management will review these results in a conference call beginning at 5:00 PM (ET).
  • The call-in number and webcast link are as follows:

Oscar Health, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Wednesday, December 20, 2023

Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, today announced that Chief Executive Officer, Mark Bertolini, is scheduled to present and provide a business update at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 at approximately 9:00 AM PT (12:00 PM ET) in San Francisco, CA.

Key Points: 
  • Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, today announced that Chief Executive Officer, Mark Bertolini, is scheduled to present and provide a business update at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 at approximately 9:00 AM PT (12:00 PM ET) in San Francisco, CA.
  • All interested parties are invited to listen to a live webcast of the presentation by visiting www.ir.hioscar.com and selecting the “Events & Presentations” link.
  • Following the presentation, a webcast replay will be available on Oscar’s investor relations website for a period of 30 days.

Oscar Health, Inc. Announces that Mark Bertolini’s Foundation and Deerfield Management have Entered into an Agreement with a Selling Shareholder to Purchase Shares of Oscar Health

Retrieved on: 
Monday, November 20, 2023

Deerfield will purchase an aggregate of 3,000,000 shares of Common Stock and Anahata will purchase an aggregate of 2,000,000 shares of Common Stock.

Key Points: 
  • Deerfield will purchase an aggregate of 3,000,000 shares of Common Stock and Anahata will purchase an aggregate of 2,000,000 shares of Common Stock.
  • The closing of each private placement is expected to occur on or about November 22, 2023, subject to the satisfaction of customary closing conditions.
  • Oscar is not a party to either of the Stock Purchase Agreements.
  • New factors emerge from time to time, and it is not possible for us to predict which will arise.

Oscar Health, Inc. Announces 2023 Culturally Competent Care Grant Recipients, Bolstering its Efforts to Support Rural and Hispanic and Latino Communities

Retrieved on: 
Monday, November 20, 2023

Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, is announcing this year’s recipients of its Culturally Competent Care (CCC) Grants.

Key Points: 
  • Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, is announcing this year’s recipients of its Culturally Competent Care (CCC) Grants.
  • The initiative, which is a component of Oscar’s CCC Program, delivers financial and on-the-ground support to select organizations who provide access to care in underserved communities.
  • With the funding, CHW anticipates serving an additional 500 individuals, and developing new Spanish literacy trainings and educational materials for the community.
  • Oscar launched the grant initiative in 2021, as a key pillar of the CCC Program, to impact change at the community level.

Oscar Health, Inc. to Present at 5th Annual Wolfe Research Healthcare Conference

Retrieved on: 
Wednesday, November 8, 2023

Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, today announced that Chief Executive Officer, Mark Bertolini, is scheduled to present and provide a business update at the 5th Annual Wolfe Research Healthcare Conference on Wednesday, November 15, 2023 at approximately 2:15 PM ET.

Key Points: 
  • Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, today announced that Chief Executive Officer, Mark Bertolini, is scheduled to present and provide a business update at the 5th Annual Wolfe Research Healthcare Conference on Wednesday, November 15, 2023 at approximately 2:15 PM ET.
  • All interested parties are invited to listen to a live webcast of the fireside chat by visiting www.ir.hioscar.com and selecting the “Events & Presentations” link.
  • Following each presentation, a webcast replay will be available on Oscar’s investor relations website for a period of 90 days.

Oscar Health, Inc. Announces 2024 Market Expansion Plans, Offering Affordable, Accessible, and Technology-Enabled Care for the Eleventh Consecutive Year

Retrieved on: 
Thursday, October 12, 2023

Oscar will offer its innovative, member-centric plans in 165 new counties, making high-quality and affordable healthcare a reality for more consumers.

Key Points: 
  • Oscar will offer its innovative, member-centric plans in 165 new counties, making high-quality and affordable healthcare a reality for more consumers.
  • The expansion will improve access to care in underserved and rural markets through Oscar’s consumer-focused technology platform.
  • “Oscar’s north star has and always will be about making great care cost less,” said Mark Bertolini, CEO of Oscar.
  • “We are making the individual market the market for everyone,” said Alessa Quane, Executive Vice President, Chief Insurance Officer of Oscar.

Oscar Health, Inc. 2023 Third Quarter Conference Call

Retrieved on: 
Tuesday, October 10, 2023

Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, will release its third quarter 2023 financial results before the market opens on Tuesday, November 7, 2023.

Key Points: 
  • Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, will release its third quarter 2023 financial results before the market opens on Tuesday, November 7, 2023.
  • Management will review these results in a conference call beginning at 8:00 AM (ET).
  • The call-in number and webcast link are as follows:

Oscar Health Welcomes Two Healthcare Veterans to its Executive Leadership Team

Retrieved on: 
Wednesday, September 6, 2023

Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built around a full stack technology platform, today announced the appointment of two seasoned healthcare executives to round out its leadership bench and further propel its vision to refactor healthcare.

Key Points: 
  • Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built around a full stack technology platform, today announced the appointment of two seasoned healthcare executives to round out its leadership bench and further propel its vision to refactor healthcare.
  • Kerry Sain has joined the company as the Executive Vice President of +Oscar, effective August 14, 2023, and Steven Kelmar will join as Executive Vice President and Chief of Staff to the CEO, effective September 21, 2023.
  • Prior to joining Oscar, Sain served as the Chief Commercial Growth Officer for Aetna, Inc., where she managed all segments across its extensive commercial markets medical business.
  • Before Aetna, she held a variety of senior leadership positions at 13D Research & Strategy, SAP America, Inc., bswift, and Mercer.

Oscar Health, Inc. to Present at Upcoming Healthcare Conferences

Retrieved on: 
Thursday, August 17, 2023

Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, today announced that Chief Financial Officer, Scott Blackley, is scheduled to present at the 2023 Wells Fargo Healthcare Conference on Wednesday, September 6, 2023 at approximately 1:30 p.m.

Key Points: 
  • Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, today announced that Chief Financial Officer, Scott Blackley, is scheduled to present at the 2023 Wells Fargo Healthcare Conference on Wednesday, September 6, 2023 at approximately 1:30 p.m.
  • In addition, Chief Executive Officer, Mark Bertolini, is scheduled to present at the Morgan Stanley 21st Annual Global Healthcare Conference on Monday, September 11, 2023 at approximately 8:00 a.m.
  • All interested parties are invited to listen to a live webcast of these presentations by visiting www.ir.hioscar.com and selecting the “Events & Presentations” link.
  • Following each presentation, a webcast replay will be available on Oscar’s investor relations website for a period of 90 days.